Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors MA Zeidan, AS Mostafa, RM Gomaa, LA Abou-Zeid, M El-Mesery, ... European journal of medicinal chemistry 168, 315-329, 2019 | 60 | 2019 |
Design and synthesis of 2‐phenyl benzimidazole derivatives as VEGFR‐2 inhibitors with anti‐breast cancer activity AS Mostafa, RM Gomaa, MA Elmorsy Chemical Biology & Drug Design 93 (4), 454-463, 2019 | 39 | 2019 |
Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton … HW El-Shafey, RM Gomaa, SM El-Messery, FE Goda Bioorganic Chemistry 101, 103987, 2020 | 21 | 2020 |
Quinazoline based HSP90 inhibitors: synthesis, modeling study and ADME calculations towards breast cancer targeting HW El-Shafey, RM Gomaa, SM El-Messery, FE Goda Bioorganic & Medicinal Chemistry Letters 30 (15), 127281, 2020 | 16 | 2020 |
Design, Synthesis and Molecular Modeling of New 1, 3, 5-Triazine Derivatives as Anticancer Agents MG Rania, AM Mohamed, ME Hassan Der Pharma Chemica 11 (5), 7-14, 2019 | 9* | 2019 |
Synthesis of new heterocyclic compounds containing benzimidazole moiety as inhibitors of breast cancer cell growth A Tantawy, A Barghash, S Badr, R Gomaa Heterocyclic Communications 19 (2), 125-131, 2013 | 7 | 2013 |
The emerging role of miRNAs in epilepsy: From molecular signatures to diagnostic potential SSA Mageed, AA Rashad, SS Elshaer, MS Elballal, OA Mohammed, ... Pathology-Research and Practice, 155146, 2024 | 1 | 2024 |
Synthesis, antitumor activities, and molecular modeling of 4-anilinoquinazoline derivatives as EGFR-TK inhibitors AH Mohammed, RM Gomaa, MAA El-Sayed, KB Selim Pharmaceutical Chemistry Journal 57 (8), 1215-1229, 2023 | 1 | 2023 |
The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies Experimental Cell Research 442 (2), 114234, 2024 | | 2024 |